Oab
Photos »
/ 
Related News »
MUSCAT -- Capital Intelligence (CI), the international credit rating agency, has announced that it has upgraded Oman Arab Bank 's ( OAB) Financial Strength Rating to 'BBB+' from 'BBB' in view of the bank's good asset quality and profitability. The Outlook ...
May 26, 2012 at 11:16 | Source: Zawya.com
AltheRx Pharmaceuticals, a privately-held clinical development company, presented positive results from its Phase II study of Solabegron in overactive bladder (OAB) at the American Urological Association Annual Meeting (Abstract # 520).
May 21, 2012 at 14:57 | Source: News-Medical.Net
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that the American Urological Association (AUA) issued a ...
May 22, 2012 at 09:05 | Source: News-Medical.Net
In phase II results presented here yesterday, the investigational beta3-adrenoceptor agonist solabegron yielded statistically significant improvements in symptoms of overactive bladder compared to placebo and was safe and well tolerated, Dutch ...
May 21, 2012 at 00:45 | Source: ModernMedicine
The fesoterodine and control groups were similar in their baseline demographics and OAB symptoms. Nearly all nocturic micturitions were associated with urgency, and mean nocturnal urgency episodes/24 hours was close to three in both study groups.
May 23, 2012 at 02:44 | Source: ModernMedicine
Solabegron produced statistically significant improvements in symptoms of overactive bladder (OAB) compared to placebo and was safe and well-tolerated Solabegron, a novel beta3-adrenoceptor agonist with high affinity and selectivity, is also in clinical ...
May 21, 2012 at 12:26 | Source: StreetInsider.com
(MENAFN Press) Oman Arab Bank's Financial Strength Rating Upgraded to 'BBB+' with a 'Stable' Outlook Capital Intelligence (CI), the international credit rating agency, today announced that it has upgraded Oman Arab Bank's (OAB) Financial Strength Rating to ...
May 24, 2012 at 18:35 | Source: MENAFN
May 23, 2012 (Atlanta, Georgia) — In women with symptoms of overactive bladder (OAB), oral solabegron, a beta-3 adrenoreceptor agonist, significantly reduced incontinence episodes with no adverse events, according to findings from a randomized placebo ...
May 23, 2012 at 17:32 | Source: Medscape News
"We will begin development of an implantable tibial nerve stimulator for the treatment of overactive bladder (OAB), and conduct a pilot study in the U.S. for the treatment of fecal incontinence using our Urgent PC Neuromodulation System," said ...
May 24, 2012 at 21:13 | Source: Marketwatch
Oman Arab Bank - Investment Management Group ( OAB-IMG), the issue manager, is also very enthused by the response. The head of OAB-IMG, Lo'ai Badie Bataineh, said, "We have received excellent response from both retail and institutional investors.
May 23, 2012 at 11:34 | Source: Zawya.com